ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
0.00%
US Tech 100
17,032.00
1.02%
다우존스 지수
37,903.29
0.00%
Bitcoin
58,813.00
0.99%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Immunovant Inc (IMVT)

  7. Immunovant Inc (IMVT) 뉴스

IMVT Immunovant Inc

28.52
0.00 (0.00%)
시간외 단일가
최종 업데이트: 19:46:57
15분 지연
기업명 주식 심볼 시장 주식 타입
Immunovant Inc IMVT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 28.52 19:46:57
개장가 저가 고가 종가 전일 종가
28.52
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/03/202420:30GLOBEImmunovant Awarded U.S. Patent for IMVT-1402
24/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202422:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202421:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/02/202421:02EDGAR2Form 8-K - Current report
30/01/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/01/202421:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/01/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202422:08EDGAR2Form 8-K - Current report
03/01/202422:00GLOBEImmunovant to Present at the 42nd Annual J.P. Morgan..
21/12/202307:40DJNImmunovant Gets Positive Data From Graves' Disease Treatment..
21/12/202306:37EDGAR2Form 8-K - Current report
21/12/202306:30GLOBEImmunovant Reports Positive Initial Phase 2 Results for..
28/11/202321:43EDGAR2Form 8-K - Current report
28/11/202321:00GLOBEImmunovant Announces Positive IMVT-1402 Initial 600 mg MAD..
25/11/202304:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202304:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202304:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202304:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:00GLOBEImmunovant to Present at Upcoming Investor Conferences
09/11/202322:49EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202321:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:06EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEImmunovant Reports Financial Results and Provides Corporate..
21/10/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:52GLOBEImmunovant Announces Closing of Upsized Common Stock..
30/09/202305:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/09/202306:23EDGAR2Form 8-K - Current report
28/09/202319:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28/09/202312:41GLOBEImmunovant Announces Pricing of $450 Million Common Stock..
27/09/202306:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/09/202306:18KRMARKETNEWS장기간 고금리와 美 정부 폐쇄 우려로 월스트리트 하락
27/09/202306:00GLOBEImmunovant Announces Proposed Offering of $300 Million of..
26/09/202320:45EDGAR2Form 8-K - Current report
26/09/202319:00GLOBEImmunovant Announces Positive Initial IMVT-1402 Phase 1 SAD..
26/09/202312:01GLOBEImmunovant to Host Conference Call and Webcast to Report..
02/09/202305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202305:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:48EDGAR2Form 8-K - Current report
17/08/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
IMVT
Immunovant
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유